In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Synlogic Inc.

www.synlogictx.com

Latest From Synlogic Inc.

Synlogic Moves Synthetic Biotics To The Clinic For Rare Metabolic Disease

Emerging Company Profile: Pioneering the development of a new class of living medicines that work in the microbiome, Synlogic completed a reverse merger earlier this year that took the company public.

StartUps and SMEs Metabolic Disorders

Appointments: BMS, Scancell, Zafgen, Cell Medica, Silence Therapeutics, Malin and Trillium

This week's roundup includes CEO appointments by Gadeta, Scancell and Zafgen, with various other high-level appointments by Malin Corporation, Cell Medica and Apeiron Biologics.

Appointments BioPharmaceutical

IPO Update: New Filings Feed Investor Fervor As Biopharma Stocks Rise

IPO launches in the US hit a wall in August, but several biopharma firms recently entered the queue, adding new opportunities for investors to chase the industry's outperforming returns.

Business Strategies Financing

Start-Up Quarterly Statistics: Private And Public Firms Were Prolific Fundraisers

A review of biopharma start-up dealmaking and financing activity from April through June 2017, based on data from Strategic Transactions, showed that fundraising activity more than doubled compared with the first quarter.

StartUps and SMEs Financing
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Gastrointestinal
  • Hepatic (Liver)
  • Immune Disorders
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Synlogic Inc.
  • Senior Management
  • Jose-Carlos Gutierrez-Ramos, PhD, CEO
    Todd Shegog, CFO
    Paul Miller, PhD, CSO
    Aoife M Brennan, MD, CMO
    Andrew Gengos, COO & Head, Corp. Dev.
  • Contact Info
  • Synlogic Inc.
    Phone: (617) 401-9947
    200 Sidney St., Ste. 320
    Cambridge, MA 02139
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register